Skip to content

Hep-2-Crithidia Luciliae Ana Test Kit

by Scripps-Miles, Inc.

510(k) K811714

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK811714 Date10 Jul 1981ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DHN
Device Class
Class II
Regulation
21 CFR Part 866.5100
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control, used for detecting antinuclear antibodies (ANA) in serum or plasma samples. It employs Crithidia luciliae cells as the substrate to identify specific immunofluorescence patterns associated with autoimmune diseases, such as systemic lupus erythematosus (SLE) or other connective tissue disorders.

The HEP-2 Crithidia Luciliae ANA Test Kit is intended for in vitro diagnostic use in clinical laboratories. Supplied as a single-use reagent, it requires no special storage conditions beyond refrigeration and is classified under FDA regulation number 866.5100 as a Class II device. Cleared via a Traditional 510(k) pathway in 1981, it adheres to immunology testing standards and is not MRI-compatible. The kit includes all necessary components for performing indirect immunofluorescence assays.

Other devices from Scripps-Miles, Inc.

See all devices from Scripps-Miles, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of autoimmune diseases can this test help identify when detecting antinuclear antibodies (ANA) using Crithidia luciliae cells?

    This test uses Crithidia luciliae cells to detect specific immunofluorescence patterns linked to autoimmune diseases, particularly systemic lupus erythematosus (SLE). It can also help identify other connective tissue disorders where ANA presence is relevant, though the exact disease correlation depends on clinical interpretation of the pattern observed.

  • Is this test kit single-use, and if so, what are the storage requirements?

    Yes, the HEP-2 Crithidia Luciliae ANA Test Kit is designed for single-use only. Storage is straightforward—no special conditions are required beyond refrigeration, ensuring stability and reliability for diagnostic use.

  • How is this device regulated, and what pathway was used for its FDA clearance?

    This device is classified as a Class II medical device under FDA regulation number 866.5100 and was cleared via the Traditional 510(k) pathway in 1981. It adheres to immunology testing standards and is intended for use in clinical laboratories performing indirect immunofluorescence assays.

  • What kind of samples can be tested with this kit, and is it compatible with any imaging modalities?

    The kit is designed for in vitro diagnostic use with serum or plasma samples. It is not MRI-compatible, so it cannot be used in magnetic resonance imaging environments.